Future-proof your HCP strategy

Challenging your current assay at the beginning of each new project and confirm your enzyme-linked immunoassay (ELISA) data by coverage assay.

Whether your host cell protein (HCP) assay development is outsourced or managed in-house, we are a trusted long-term partner for the reliable data and security of supply you need for efficient drug development — through our broad product offering and scientific support.

• Generic ELISA and stand-alone antibody
• Coverage consumables
• Imaging systems: Amersham™ Typhoon™ laser scanner, Amersham™ ImageQuant™ 800 biomolecular imager
• Analysis software: ImageQuant™ GxP for 1D analysis, Melanie™ software for 2D analysis
• DIBE™ training, service, and scientific support

Cytiva enables you to prebook your antisera batch for the entire drug development lifecycle and beyond. Our certificate of analysis will indicate which antisera batch you validated. We store the raw material for you, and we ship it to you on a regular basis.

Find out how through our security of supply for critical reagents used in HCP analysis webinar.

With more than 20 years of expertise, our consumables were developed to support 2D elctrophoresis for HCP coverage and give you a solution that provides the highest sensitivity and resolution.

ImageQuant™ 800 GxP is specifically designed to meet the increasing requirements of regulations like FDA 21 CFR part 11 and EU GMP Annex 11 — where data traceability, accountability, and integrity are critical.

A coverage assay validates ELISA antibody performance in HCP analysis. A high percent coverage provides confidence in meeting regulatory requirements. But all coverage assays are not created equal.

An HCP coverage assay should be sensitive, accurate, rapid, and objective. Contact us to request more information on our HCP coverage assay recommendations and learn how we can support your HCP analysis.